Regarding the features of PC, the prostate-specific antigen (PSA) level (P = 0.016) and tumor T stage (P = 0.047) were significantly higher, and brachytherapy was significantly less likely to have been performed (P < 0.001) in the ADT group compared to the control group. The gene discussed is KLK3; the disease is neoplasm.